Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02267928 · ClinicalTrials.gov registry record · NA
Information Presentation Formats
A NA study of Meningioma, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
- 1
- Study location
NCT02267928: Completed NA study of Meningioma, sponsored by Carnegie Mellon University.
NCT02267928 is a NA study of Meningioma that has completed, run by Carnegie Mellon University. The registered enrollment target is 305 participants, above the 85-participant average among 21 other Meningioma trials with a reported enrollment target (259% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02267928, a NA study of Meningioma, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
- 1
- Study location
Study Summary
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
Primary Outcome
The number of symptoms checked off by participants
Conditions Studied
Interventions
- OTHER Check Symptoms
- OTHER Uncheck Symptoms
- OTHER Experienced
- OTHER Not Experienced
Study Locations (1)
Pennsylvania
- Carnegie Mellon University - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02267928 record still lists
NCT02267928 is an interventional study that assigns participants to a tested intervention. The registered 305 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 21 other Meningioma trials with a reported enrollment target (259% higher).
The record links to 1 condition, with Meningioma appearing as the primary indexed condition, and to 4 interventions - of which Check Symptoms is the first listed.
NCT02267928 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02267928 about?
NCT02267928 is a clinical study titled "Information Presentation Formats". Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the ...
What is the current status of trial NCT02267928?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2014-10. Estimated completion is 2016-05.
What conditions does trial NCT02267928 study?
This clinical trial studies the following conditions: Meningioma.
What interventions are being tested in trial NCT02267928?
The interventions under investigation include: Check Symptoms (OTHER), Uncheck Symptoms (OTHER), Experienced (OTHER), Not Experienced (OTHER).
Who is sponsoring clinical trial NCT02267928?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02267928 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meningioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02267928's enrollment target sits among peer trials
305 2nd of 21 the highest of 21 other Meningioma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Meningioma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
RECRUITING · NA
-
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
ACTIVE NOT RECRUITING · NA
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
-
Abemaciclib in Newly Diagnosed Meningioma Patients
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04107181 · 305 participants · NA
Pilot Study for Speculum Free Cervical Cancer Screening
- NCT05399056 · 305 participants · NA
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia